Motavizumab

We can tell you that Motavizumab is a…

• …Drug
• …Medical Treatment

If you know more about Motavizumab, you can add more facts here »

Similar topics in Freebase

• Igovomab

  Igovomab (trade name Indimacis-125) was a mouse monoclonal antibody for the diagnosis of ovarian cancer. Linked to the chelating agent DTPA and labelled with Indium-111, it was used for imaging (radio-immuno scintigraphy) of the cancer. The drug is no longer available.

• CAM-3001

• Priliximab

  Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licencing. The patent belongs to the biotechnology company Centocor.

• CAT-354

• CAT-8015

• Libivirumab

  Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.

• Efungumab

  Efungumab (trade name Mycograb) is a human monoclonal antibody developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat invasive Candida infection in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb,...

• Ertumaxomab

  Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. As of September 2009, a Phase II clinical trial evaluating the treatment of breast cancer is recruiting participants. It works by linking T-lymphocytes and macrophages to the cancer...

• Palivizumab

  Palivizumab (brand name Synagis or Abbosynagis) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of Respiratory Syncytial Virus (RSV) infections. It is recommended for certain infants that are high-risk (because of prematurity or other medical problems),...

• Lexitumumab